0001994868-23-000002.txt : 20231205 0001994868-23-000002.hdr.sgml : 20231205 20231205111256 ACCESSION NUMBER: 0001994868-23-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231205 DATE AS OF CHANGE: 20231205 EFFECTIVENESS DATE: 20231205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avalor Therapeutics, Inc. CENTRAL INDEX KEY: 0001994868 IRS NUMBER: 861894283 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-498811 FILM NUMBER: 231465585 BUSINESS ADDRESS: STREET 1: 16013 32ND AVENUE NE CITY: LAKE FOREST STATE: WA ZIP: 98155 BUSINESS PHONE: 805-637-6529 MAIL ADDRESS: STREET 1: 16013 32ND AVENUE NE CITY: LAKE FOREST STATE: WA ZIP: 98155 D 1 primary_doc.xml X0708 D LIVE 0001994868 Avalor Therapeutics, Inc. 6700 NE 181st St., #82506 Kenmore WA WASHINGTON 98028 8056376529 DELAWARE None None Corporation true 2020 William E. Martinez Zegarra 6700 NE 181st St., #82506 Kenmore WA WASHINGTON 98028 Executive Officer Director Kenneth Wild 6700 NE 181st St., #82506 Kenmore WA WASHINGTON 98028 Director Anthony Ford 6700 NE 181st St., #82506 Kenmore WA WASHINGTON 98028 Director Biotechnology Decline to Disclose 06b false 2023-08-01 false true false 25000 800000 335000 465000 false 6 0 0 0 false Avalor Therapeutics, Inc. William E. Martinez Zegarra William E. Martinez Zegarra President 2023-12-05